


|
|
|
Insider Transactions
Date  |
Name |
Title |
Type |
Shares Traded |
Price Range |
| Nov 19, 2007 |
skystone advisors llc |
Beneficial Owner (10% or more) |
Buy |
7,164 |
3.74 |
| Nov 20, 2007 |
hso limited partnership |
Beneficial Owner (10% or more) |
Buy |
5,617 |
3.87 |
| Nov 20, 2007 |
skystone advisors llc |
Beneficial Owner (10% or more) |
Buy |
9,177 |
3.87 |
| Dec 11, 2007 |
Lewis, Earl R. |
Director |
Buy |
25,000 |
4.25 - 4.40 |
| Dec 11, 2007 |
Uveges, George |
Director |
Buy |
4,000 |
4.10 - 4.15 |
| Dec 12, 2007 |
Uveges, George |
Director |
Buy |
1,000 |
4.21 |
| Dec 31, 2007 |
skystone advisors llc |
Beneficial Owner (10% or more) |
Buy |
4,362 |
4.51 |
| May 16, 2008 |
hso limited partnership |
Beneficial Owner (10% or more) |
Sell |
733,300 |
5.00 |
| May 16, 2008 |
skystone advisors llc |
Beneficial Owner (10% or more) |
Sell |
1,000,000 |
5.00 |
| Nov 26, 2008 |
Uveges, George |
Director |
Buy |
2,500 |
1.95 - 1.96 |
| Dec 1, 2008 |
Green, David |
Officer |
Automatic Buy |
10,000 |
1.98 - 2.00 |
| Dec 1, 2008 |
Lewis, Earl R. |
Director |
Buy |
10,000 |
2.03 |
| Dec 2, 2008 |
Green, David |
Officer |
Automatic Buy |
3,200 |
2.00 |
| Dec 2, 2008 |
Lewis, Earl R. |
Director |
Buy |
15,000 |
2.00 - 2.10 |
| Dec 3, 2008 |
Green, David |
Officer |
Automatic Buy |
1,400 |
2.00 |
| Dec 4, 2008 |
Green, David |
Officer |
Automatic Buy |
10,000 |
1.97 - 2.00 |
| Dec 5, 2008 |
Green, David |
Officer |
Automatic Buy |
100 |
2.00 |
| Dec 19, 2008 |
Green, David |
Officer |
Automatic Buy |
10,000 |
2.37 - 2.50 |
| Dec 22, 2008 |
Green, David |
Officer |
Automatic Buy |
10,000 |
2.44 - 2.50 |
| Jan 27, 2009 |
Green, David |
Officer |
Automatic Buy |
2,100 |
2.45 - 2.49 |
|
|
Stock transaction information provided by EDGAR Online. Harvard Bioscience, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.
|
|
|